Dr. Godwin on Immunotherapy Efforts in Prostate Cancer – OncLive
|
Dr. Godwin on Immunotherapy Efforts in Prostate Cancer
OncLive Immunotherapy in prostate cancer is a complex topic, says Godwin. Of the genitourinary malignancies that physicians treat, prostate cancer has been the most resistant to immunotherapy compared with renal cell carcinoma and urothelial carcinoma. |
